skip to primary navigationskip to content

Dr Camilo Colaco

Dr Camilo Colaco

Camilo Colaco is available for consultancy.

Research Interests

Development of vaccines targeting Dendritic cells and DC-based cancer immunotherapy. Specifically utilisation of heat shock protein complexes and Fc-tags to target antigens to DC for activation of both innate and acquired immune responses


hspCs ; immunotherapy ; vaccines ; immunobiology ; dendritic cells


  • vaccines
  • transplantation

Key Publications

Colaco CA, Bailey CR, Walker KB, Keeble J. Heat shock proteins: stimulators of innate and acquired immunity. Biomed Res Int. 2013;2013:461230.

McNulty S, Colaco CA, Blandford LE, Bailey CR, Baschieri S, Todryk S. Heat shock proteins as dendritic cell-targeting vaccines - getting warmer. Immunology. 2013 Apr 2
Colaco C. Autologous heat-shock protein vaccines. Human Vacc. Immunother. (2013) 9, 1-2.
Loureiro S., Ren J., Phapugrangkul P., Colaco C.A., Bailey C.R., Shelton H., Molesti E., Temperton N.J., Barclay W.S. and Jones I.M. Adjuvant free immunisation with Hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. J Virol. (2011) 85, 3010-3014.
Wright D.E, Colaco S., Colaco C. & Stevenson P.G. Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions. J. Gen. Virol. (2009) 90, 2592-2603.
Colaco C.A.L.S. Cancer Immunotherapy, simply cell biology. Molecular Medicine Today (2003). 12, 515-516.
Colaco C.A.L.S. Why DCs are central to cancer immunotherapy. Molecular Medicine Today (1999). 5, 14-17.